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Dermal fibroblasts from acute inflamed 
atopic dermatitis lesions display increased 
eotaxin⁄ CCL11 responsiveness to 
interleukin-4 stimulation
Gahr et al. cultured dermal fibroblasts derived from biop-
sies obtained from healthy individuals and from chronic 
lesional and acute lesional skin of atopic patients, and 
compared dose–response profiles of interleukin (IL)-4-
induced CCL11 mRNA expression using gel-based and 
real-time reverse transcription–polymerase chain reac-
tion. Lower half maximal responses (EC50) of IL-4-induced 
CCL11 expression in fibroblasts from acute inflamed atopic 
skin lesions indicated increased IL-4 responsiveness in 
these lesions and further substantiated the special role for 
IL-4-induced dermal fibroblast CCL11 expression in acute 
lesions. Variable CCL11 expression in fibroblasts from dif-
ferent patients with atopic derma titis (AD) indicated het-
erogeneity of factors determining atopic phenotype in AD. 
Br J Dermatol 2011; 164: 586–92.
CEDNIK syndrome results from loss-of-
function mutations in SNAP29
Fuchs-Telem et al. identified a novel homozygous inser-
tion in SNAP29 (c.486insA) in two siblings presenting 
with ichthyosis and dysgenesis of the corpus callosum. In 
vitro transfection experiments indicated that this mutation 
results in SNAP29 loss-of-function. Further substantiating 
this notion, histological features were replicated, typical for 
CEDNIK syndrome, in three-dimensional primary human 
keratinocyte organotypic cell cultures downregulated for 
SNAP29. Identification of a second mutation in SNAP29 in 
the present study confirms the causal relationship between 
defective function of SNAP29 and the pleiotropic manifes-
tations of CEDNIK syndrome, and lends further support for 
an essential role played by this molecule during epidermal 
differentiation. Br J Dermatol 2011; 164: 610–16.
The sap from Euphorbia peplus is effective 
against human nonmelanoma skin cancers
This clinical study affirms community experience with 
E. peplus and supports further clinical development of 
PEP005 for the treatment of basal cell carcinoma (BCC), 
squamous cell carcinoma and intraepidermal carcinoma 
(IEC). Forty-three per cent of lesions had failed previous 
treatments, 35% were situated in the head and neck region, 
and 30% were > 2 cm in diameter. For superficial lesions 
< 16 mm, the response rates after follow up were 100% for 
IEC (n = 10) and 78% for BCC (n = 9). The results are thus 
comparable with existing nonsurgical modalities, with low 
toxicity and favourable cosmesis. Br J Dermatol 2011; 164: 
633–36.
An action spectrum for ultraviolet  
radiation-induced immunosuppression  
in humans
The relative contributions of ultraviolet (UV) A and UVB to 
immunosuppression by incidental daily sun exposure are 
unclear. Damian et al. used the nickel model of recall con-
tact hypersensitivity to determine UV immunosuppression 
dose responses and minimum immune suppression doses 
at 11 narrowbands from 289 to 392 nm. The human action 
spectrum for UV-induced immunosuppression was shown 
to peak at 300 nm (UVB) and 370 nm (UVA). Sunlight con-
tains ~100 fold more UV at 370 nm than at 300 nm. Hence 
longwave UVA, which is less effectively filtered by sun-
screens, is likely to be the main contributor to UV immu-
nosuppression during daily, incidental sun exposure. Br J 
Dermatol 2011; 164: 657–59.
A systematic investigation  
of confirmed autoimmune loci  
in early-onset psoriasis reveals  
an association with IL2 ⁄IL21
The purpose of this investigation was to study 21 genet-
ic variants in 14 genes that are confirmed autoimmune 
loci, in a cohort of patients with early-onset psoriasis. 
Authors report strong evidence for the association of ear-
ly-onset psoriasis with two variants in the IL2 ⁄IL21 region 
(rs6822844, genotypic P = 3⋅3 x 10-4; rs2069778, geno-
typic P = 7⋅86 x 10-4). The findings, although requiring 
validation, suggest that IL2 ⁄IL21 may play a key role in the 
pathogenesis of psoriasis as well as in other diverse auto-
immune diseases. Br J Dermatol 2011; 164: 660–64.
